Bringing The World Home To You

© 2025 WUNC North Carolina Public Radio
120 Friday Center Dr
Chapel Hill, NC 27517
919.445.9150 | 800.962.9862

Donate

Play Live Radio

Next Up:

0:00

0:00 0:00

Available On Air Stations

Already a Sustainer? Click here to increase now →

Patients turn to 'gray market' for cheaper obesity drugs, but it's risky

By Sydney Lupkin

Published October 7, 2025 at 5:05 PM EDT

Patients who want a deeper discount on obesity meds than compounding pharmacies can offer are turning to the gray market, where they buy the raw active ingredient from China and prepare it themselves.

Sydney Lupkin

Sydney Lupkin is the pharmaceuticals correspondent for NPR.

See stories by Sydney Lupkin

Stories From This Author

President Trump announces deal with Pfizer to sell its drugs on federal website

Sydney Lupkin

President Trump on Tuesday announced a deal with Pfizer to sell its drugs directly to consumers at discounted prices. They'll be available through a website operated by the federal government.
President announces TrumpRx website for drugs, and pricing deal with Pfizer

Sydney Lupkin

The Trump administration says it is making deals with drug companies to lower prices U.S. consumers pay for medicines. But key details are missing on how the initiative would work.
Trump deadline for drugmakers to lower prices comes due

Sydney Lupkin

The Trump administration sent letters this summer to 17 makers of name-brand drugs pushing them to lower prices to align them with what other countries pay. The companies had 60 days to "step up."